.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Deloitte
Cerilliant
McKesson
Johnson and Johnson
Chinese Patent Office
Citi
Baxter
McKinsey

Generated: September 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: HCG liquid formulations
Abstract:The invention refers to liquid pharmaceutical compositions containing hCG stabilised with a polyalcohol or a non-reducing sugar. Preferably, the compositions are stabilised with mannitol. In the preferred embodiments such compositions are aqueous solutions in a phosphate buffer at pH 7. Such compositions are ready to be injected and, therefore, the step of reconstitution of the lyophilised powder is avoided, thus simplifying the way of use.
Inventor(s): Samaritani; Fabrizio (Rome, IT), Natale; Patrizia (Rome, IT)
Assignee: Applied Research System ARS Holding N.V. (Antilles, NL)
Application Number:08/913,748
Patent Claims: 1. A stable, liquid pharmaceutical composition comprising recombinant human Chorionic Gonadotropin and a stabilizing amount of mannitol.

2. A liquid pharmaceutical composition according to claim 1, wherein the solution is a buffered aqueous solution.

3. A liquid pharmaceutical composition according to claim 2, wherein the buffer solution is selected from the group consisting of acetate, succinate and phosphate buffer.

4. A liquid pharmaceutical composition according to claim 3, wherein the buffer is phosphate buffer.

5. A liquid pharmaceutical according to claim 2, wherein the buffer solution is at pH 7.0.

6. A liquid pharmaceutical composition according to claim 2, wherein the buffer solution is 0.01 M.

7. A liquid pharmaceutical composition according to claim 1, comprising from 1,000 to 40,000 IU/ml of rhCG and from 10 to 180 mg/l of mannitol in a 0.01 M phosphate buffer at pH 7.0.

8. A process for the preparation of a liquid pharmaceutical composition according to claim 1, comprising diluting a rhCG bulk solution in a buffer solution containing exipients.

9. The liquid pharmaceutical composition of claim 1 hermetically closed in a sterile condition in a container suitable for the storage before use.

10. A liquid pharmaceutical composition according to claim 3, wherein the buffer solution is at pH 7.0.

11. A liquid pharmaceutical composition according to claim 4, wherein the buffer solution is at pH 7.0.

12. A liquid pharmaceutical composition according to claim 3, wherein the buffer solution is 0.01 M.

13. A liquid pharmaceutical composition according to claim 4, wherein the buffer solution is 0.01 M.

14. A liquid pharmaceutical composition according to claim 5, wherein the buffer solution is 0.01 M.

15. A liquid pharmaceutical composition according to claim 10, wherein the buffer solution is 0.01 M.

16. A liquid pharmaceutical composition according to claim 11, wherein the buffer solution is 0.01 M.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
Cipla
Johnson and Johnson
Medtronic
Express Scripts
Novartis
Daiichi Sankyo
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot